 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Admighty Foundation |
| Street 1: | 408,Narayan Arcade |
| Street 2: | Narol-Aslali Highway,Narol |
| City: | Ahmedabad |
| Province: | Gujarat |
| Post Code: | 382405 |
| Country: | India |
| Phone: | 9873522666 |
| Organization Email: | admightyfoundation@gmail.com |
| Web Site: | http://www.admightyfoundation.org |
| Other Online Presence: | www.facebook.com/admightyfoundation |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | U80301HR2019NPL080185 |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Community-Based Organization (CBO) |
| Organization Description: | |
| The Admighty Foundation originated from a vision that encapsulates the founder’s essence and the collective aspirations of a group of fervent individuals dedicated to improving the world. Initiated in 2019 by Dinesh Kr Gautam, an eminent philanthropist and environmentalist, the Foundation initially endeavoured to tackle the interrelated challenges of health, education, and the environment. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Advocacy Civil Society and Community Engagement Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance Working on Community, Rights and Gender (CRG) |
Other Organization Information | |
| Total number of staff in your organization: | 1 - 5 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 6 - 10 |
| Number of volunteers who are directly involved with TB: | 11 - 25 |
| How did you hear about the Stop TB Partnership: | Other partners |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | NA |
| Why do you wish join the Stop TB Partnership: | Resource mobilization |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Approach Humanitarian: We believe in the provision of humanitarian assistance to people wherever it is needed to relieve suffering and sickness. Inclusive: We believe that partnerships with individuals, other organisations and communities promote creative and fruitful initiatives. Impact: We believe that people in communities and aid agencies should be empowered to develop skills for immediate and future disaster response. Professional: Our staff, members and partners are professional people committed to providing high quality training and expertise in disaster relief and rehabilitation. Impartial: We work with people regardless of race, religion or political affiliation. Respect: We believe people affected by any social or medical can and should be empowered to contribute to relief, rehabilitation and development efforts. |
|
Geographical Reach | |
| Which country is your headquarters located in: | India |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
India |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Admighty Foundation is committed to improving Tuberculosis (TB) care delivery through a holistic approach that integrates advocacy, communications, and social mobilization (ACSM). Recognizing that TB is not just a medical issue but also a social and economic challenge, the Foundation’s initiatives aim to address the barriers to TB care by creating awareness, empowering communities, and strengthening health systems. Advocacy Initiatives Policy Advocacy Engaging with government agencies, policymakers, and international organizations to strengthen TB-related policies and programs. Advocating for increased funding and resource allocation for TB prevention, treatment, and research. Promoting the adoption of patient-centered care models in alignment with global standards such as the WHO's End TB Strategy. Collaboration with Stakeholders Partnering with healthcare providers, non-governmental organizations (NGOs), and private sector entities to create an integrated response to TB care delivery. Highlighting the importance of multi-sectoral collaboration to address social determinants of TB, such as poverty, malnutrition, and lack of access to healthcare. Rights-Based Advocacy Ensuring that TB patients have access to equitable, stigma-free, and quality care. Promoting the inclusion of marginalized and high-risk populations, such as migrant workers and people in rural areas, in TB programs. Communications Campaigns Awareness Campaigns Launching multimedia campaigns to educate the public on TB prevention, symptoms, and the importance of timely diagnosis and treatment. Using traditional and digital platforms, including social media, community radio, and local events, to disseminate accurate and relatable information. Combating Stigma Designing targeted communications to reduce stigma surrounding TB, which often discourages individuals from seeking care. Sharing real-life stories of TB survivors to foster empathy and inspire early treatment-seeking behavior. Behavioral Change Communication (BCC) Creating culturally relevant and community-specific materials to promote positive health behaviors, such as treatment adherence and infection control. Training healthcare workers to deliver patient-centered messages that build trust and encourage participation in TB care. Social Mobilization Efforts Community Empowerment Engaging community leaders, influencers, and local organizations to promote TB awareness and drive participation in prevention and care programs. Empowering affected communities to play an active role in identifying barriers to care and developing localized solutions. Youth and School Engagement Conducting school-based programs and youth campaigns to educate younger generations about TB prevention and reduce misinformation. Training young advocates to serve as TB ambassadors within their communities. Grassroots Mobilization Organizing door-to-door campaigns and health fairs to ensure that TB awareness and services reach remote and underserved areas. Establishing community TB support groups to encourage peer learning, emotional support, and treatment adherence. Innovative Approaches to ACSM Digital Outreach Leveraging mobile health (mHealth) technologies to deliver reminders, educational content, and motivational messages to TB patients. Using data analytics to target high-burden areas with tailored communications. Community-Based Monitoring Training community volunteers to monitor TB cases, track treatment progress, and report challenges faced by patients. Ensuring accountability by involving communities in assessing the effectiveness of TB programs. Cultural Sensitivity Designing ACSM initiatives that respect cultural norms and practices, ensuring that messages resonate with diverse populations. Outcomes and Impact Through its ACSM initiatives, Admighty Foundation has achieved: Increased Awareness: A significant rise in knowledge about TB prevention, symptoms, and treatment options within target communities. Enhanced Treatment Adherence: Improved adherence to TB treatment regimens by addressing stigma and fostering trust in healthcare services. Community Ownership: Greater involvement of local communities in TB care delivery, creating sustainable models for long-term impact. Alignment with Global Goals Admighty Foundation’s TB care delivery initiatives align with: The United Nations Sustainable Development Goal 3 (SDG 3): Ensure healthy lives and promote well-being for all by combating TB and other infectious diseases. The End TB Strategy: Promoting universal access to TB care and fostering community engagement to reduce TB deaths and transmission. Vision for the Future Admighty Foundation envisions a world where communities are informed, empowered, and proactive in combating TB. By integrating advocacy, communications, and social mobilization into its TB care delivery model, the Foundation is not only addressing the medical aspects of the disease but also dismantling the social and systemic barriers that hinder progress toward a TB-free future. Drug-Resistant TB: Admighty Foundation is deeply committed to combating the growing threat of Drug-Resistant Tuberculosis (DR-TB), a significant global health challenge. As cases of Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) continue to rise, the Foundation has developed comprehensive initiatives to address this pressing issue through prevention, research, treatment innovation, and community engagement. Key Pillars of the DR-TB Initiatives Early Detection and Diagnosis Advanced Diagnostics: Admighty Foundation promotes the use of cutting-edge diagnostic tools, such as GeneXpert, Whole Genome Sequencing, and Line Probe Assays, for the rapid and accurate detection of DR-TB. Community-Based Screening: Mobile diagnostic camps are set up in high-burden areas to increase accessibility and detect DR-TB cases early, especially among vulnerable populations. Targeted Testing: Special focus is placed on at-risk groups, including individuals with a history of incomplete TB treatment, healthcare workers, and close contacts of DR-TB patients. Treatment Innovations Shortened Regimens: The Foundation is actively involved in piloting and promoting shorter, more effective drug regimens, such as the Bedaquiline-containing regimen and delamanid-based therapies, to improve treatment outcomes for MDR-TB and XDR-TB patients. Personalized Medicine: Collaborating with research institutions, Admighty Foundation is exploring personalized treatment approaches based on genetic resistance profiles to enhance drug efficacy and minimize side effects. Integrated Care Models: Holistic care is provided, including nutritional support, mental health services, and treatment adherence counseling, to improve overall patient well-being. Capacity Building Healthcare Worker Training: Admighty Foundation conducts specialized training programs for doctors, nurses, and lab technicians on managing DR-TB cases and handling complex treatment protocols. Strengthening Health Systems: Support is provided to government and local health facilities to enhance their capacity for diagnosing, treating, and monitoring DR-TB cases effectively. Community Engagement and Support Patient Support Groups: Peer networks are established to provide emotional support, share experiences, and encourage treatment adherence among DR-TB patients. Stigma Reduction: Targeted campaigns are implemented to educate communities about DR-TB, dispel myths, and reduce the stigma associated with the disease. Family-Centered Care: The Foundation involves families in the treatment process, ensuring they have the knowledge and resources to support their loved ones. Advocacy and Policy Influencing Policy: The Foundation advocates for increased government funding, policy reform, and prioritization of DR-TB in national health agendas. Access to Medications: Efforts are made to ensure the availability and affordability of second-line drugs for DR-TB patients, particularly in low-resource settings. Global Collaboration: Admighty Foundation works closely with international organizations such as WHO, Stop TB Partnership, and other stakeholders to align its efforts with global DR-TB strategies. Research and Innovation Drug Resistance Studies: The Foundation conducts research to understand the molecular mechanisms of drug resistance, enabling the development of novel treatment strategies. Operational Research: Studies are undertaken to evaluate the effectiveness of DR-TB interventions, optimize care delivery models, and scale successful approaches. Vaccine Research: Admighty Foundation supports research into next-generation vaccines that can prevent TB and reduce the risk of DR-TB development. Monitoring and Evaluation Real-Time Data Systems: Digital platforms are used to monitor patient outcomes, identify gaps in care, and ensure timely interventions. Treatment Outcome Analysis: Regular assessments are conducted to evaluate cure rates, treatment adherence, and relapse prevention strategies. Achievements and Impact Increased Case Detection: Significant improvement in the identification of DR-TB cases through community-based screenings and advanced diagnostics. Improved Treatment Success Rates: The introduction of shorter, more effective regimens has resulted in better treatment adherence and outcomes. Community Empowerment: Local communities are more informed and actively engaged in supporting DR-TB patients and combating stigma. Global Contributions: Admighty Foundation’s initiatives contribute to global efforts to end the DR-TB epidemic, aligning with the WHO’s End TB Strategy. Challenges Addressed by Admighty Foundation Treatment Barriers: By introducing shorter regimens and personalized medicine, the Foundation addresses issues related to long treatment durations and severe side effects. Healthcare Gaps: Training programs and resource allocation strengthen healthcare systems in underserved regions. Stigma and Awareness: Community engagement initiatives reduce the social stigma and misinformation surrounding DR-TB. Vision for a DR-TB-Free World Admighty Foundation envisions a future where no individual suffers from drug-resistant TB due to a lack of access to timely diagnosis, effective treatment, or adequate support. Through its multi-faceted approach, the Foundation is empowering patients, strengthening healthcare systems, and driving innovation to eliminate DR-TB as a public health threat. With its commitment to sustainable and scalable solutions, Admighty Foundation continues to inspire hope and lead the fight against one of the most formidable challenges in global health. TB-HIV: Recognizing the critical intersection between Tuberculosis (TB) and HIV, Admighty Foundation has designed and implemented targeted initiatives to address the dual epidemic. As HIV weakens the immune system, people living with HIV (PLHIV) are significantly more susceptible to TB, which remains a leading cause of death among them. Admighty Foundation’s TB-HIV initiatives aim to integrate care, enhance accessibility, and improve health outcomes through comprehensive strategies and community engagement. Key Components of TB-HIV Initiatives Integrated TB-HIV Services Screening and Co-Testing: Ensuring that all TB patients are tested for HIV and all PLHIV are screened for TB symptoms as a routine part of care. Using advanced diagnostic tools like GeneXpert for TB detection in PLHIV to ensure early and accurate diagnosis. One-Stop Clinics: Establishing integrated care centers where patients can access TB and HIV testing, treatment, and counseling in one location. Streamlined Referral Systems: Strengthening referral mechanisms between TB and HIV healthcare facilities to reduce delays in diagnosis and treatment. Antiretroviral Therapy (ART) and TB Treatment Integration Ensuring that PLHIV diagnosed with TB are initiated on TB treatment without delay while continuing ART. Training healthcare workers to manage drug-drug interactions between anti-TB medications and antiretroviral drugs. Promoting shorter and effective drug regimens, like those including Bedaquiline, to minimize treatment complexity. Prevention Efforts Isoniazid Preventive Therapy (IPT): Offering IPT to PLHIV without active TB to prevent latent TB infection from becoming active. HIV Prevention in TB Patients: Providing access to condoms, Pre-Exposure Prophylaxis (PrEP), and harm reduction services to TB patients at high risk of HIV. Vaccination: Advocating for early Bacillus Calmette-Guérin (BCG) vaccination in HIV-exposed infants to reduce the risk of severe TB. Community Engagement and Awareness Awareness Campaigns: Conducting campaigns to educate communities about the link between TB and HIV, emphasizing the importance of early detection and treatment adherence. Peer Support Networks: Establishing peer-led support groups for people co-infected with TB and HIV to share experiences, provide emotional support, and encourage adherence to treatment. Stigma Reduction: Addressing stigma associated with both TB and HIV through targeted communication and engagement with community leaders. Capacity Building Training Healthcare Workers: Equipping healthcare providers with skills to deliver integrated TB-HIV care, including management of complex co-infections. Health System Strengthening: Providing resources and technical support to health facilities to enhance TB-HIV service delivery, particularly in high-burden areas. Research and Data-Driven Interventions Operational Research: Conducting studies to identify barriers to TB-HIV service integration and develop innovative solutions to overcome them. Surveillance and Monitoring: Utilizing data systems to monitor co-infection rates, treatment outcomes, and adherence patterns to inform program improvements. Collaborative Research: Partnering with academic and research institutions to explore new treatments, diagnostics, and preventive strategies for TB-HIV co-infections. Advocacy and Policy Engagement Advocating for policies that prioritize TB-HIV integration in national health agendas. Promoting global and national commitments to reduce the burden of TB and HIV through coordinated efforts. Encouraging increased funding and resource allocation for TB-HIV programs. Achievements and Impact Improved Case Detection: Increased rates of TB diagnosis among PLHIV and vice versa through routine screening and integrated services. Enhanced Treatment Outcomes: Higher adherence and cure rates among co-infected patients due to streamlined care and comprehensive support. Community Empowerment: Greater community awareness about TB-HIV co-infection, reducing stigma and encouraging early treatment-seeking behavior. Strengthened Health Systems: Enhanced capacity of healthcare facilities to deliver integrated TB-HIV care in resource-limited settings. Alignment with Global Goals Admighty Foundation’s TB-HIV initiatives align with: The United Nations Sustainable Development Goals (SDGs), particularly SDG 3.3, which aims to end epidemics of AIDS, TB, and other communicable diseases by 2030. The WHO End TB Strategy and the UNAIDS 95-95-95 targets, focusing on integrated and patient-centered care for TB and HIV. Vision for the Future Admighty Foundation envisions a future where TB and HIV are no longer life-threatening for co-infected individuals. Through integrated care, innovative approaches, and community-driven strategies, the Foundation is committed to addressing the dual burden of TB and HIV, empowering patients, and contributing to global efforts to end both epidemics. Fundamental Research: Admighty Foundation, a non-profit organization with a mission to address critical health challenges, is deeply committed to combating Tuberculosis (TB) through fundamental research and innovative interventions. As TB remains a global health threat, particularly in underprivileged and vulnerable communities, the Foundation aims to contribute to the global efforts to eliminate this disease by exploring groundbreaking solutions. Objectives of TB Fundamental Research Decoding the Disease Pathology Admighty Foundation focuses on understanding the fundamental biological and molecular mechanisms of TB, including the interaction between the Mycobacterium tuberculosis bacterium and the host immune system. This research is crucial to uncovering new targets for diagnostics, therapeutics, and vaccines. Exploring Drug Resistance Mechanisms The emergence of Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) poses a significant challenge to current treatment protocols. The Foundation’s research delves into the genetic and biochemical pathways responsible for drug resistance, enabling the development of advanced treatments. Innovative Diagnostic Tools Early and accurate detection is critical to curbing the spread of TB. Admighty Foundation is researching affordable and rapid diagnostic technologies that can be deployed in low-resource settings, ensuring accessibility for marginalized populations. Vaccine Development The Foundation is engaged in exploring novel vaccine candidates and improving the efficacy of existing vaccines. Its research focuses on developing immunization strategies that offer long-lasting protection and are effective against drug-resistant strains. Host-Pathogen Interaction Studies Understanding how TB bacteria evade the immune system is key to designing effective interventions. Admighty Foundation conducts research to uncover how the bacterium persists in the host and causes latent or active TB. Environmental and Nutritional Factors The Foundation also studies the role of environmental and nutritional factors in TB susceptibility and recovery. This research supports the development of holistic care models that include nutritional supplementation as a key component of TB treatment. Collaborative Approach Admighty Foundation adopts a collaborative and multi-disciplinary approach to TB research, working closely with: Academic and research institutions. Healthcare organizations. National and international public health bodies. These collaborations enable resource sharing, knowledge exchange, and the translation of research into actionable solutions. Community-Centric Research A unique aspect of Admighty Foundation’s research is its community-oriented focus. By working at the grassroots level, the Foundation collects real-world data on TB incidence, treatment adherence, and socio-economic impacts. This information guides the design of tailored interventions and policies that address the needs of affected communities. Contribution to Global Health Goals Admighty Foundation’s work on TB aligns with global health initiatives, including: The World Health Organization’s End TB Strategy, which seeks to reduce TB deaths and incidence rates globally. The United Nations Sustainable Development Goals (SDG 3), focusing on ensuring healthy lives and promoting well-being for all by ending epidemics like TB. Advocacy and Awareness In addition to research, the Foundation plays a pivotal role in advocacy by: Raising public awareness about TB prevention, treatment, and care. Fighting stigma associated with the disease. Encouraging early diagnosis and adherence to treatment protocols. Vision for the Future Admighty Foundation envisions a TB-free world where advanced scientific research and community-centric interventions combine to eliminate this disease. By addressing the medical, social, and environmental dimensions of TB, the Foundation aims to transform public health outcomes and contribute to a healthier, more equitable future. Through its commitment to innovation, collaboration, and impact, Admighty Foundation continues to drive change in the fight against TB, bringing hope to millions affected by this preventable and curable disease. Research: Admighty Foundation, a non-profit organization with a strong commitment to addressing global health challenges, has prioritized Tuberculosis (TB) as a focal area of its research initiatives. Recognizing TB as one of the deadliest infectious diseases, particularly in low-income and vulnerable communities, the Foundation is dedicated to advancing research that can lead to innovative solutions and impactful interventions. Key Focus Areas of TB Research Innovative Diagnostics Admighty Foundation is working on developing affordable, rapid, and highly sensitive diagnostic tools to detect TB at its earliest stages. These diagnostics aim to be accessible in resource-constrained settings, particularly in rural and underserved areas, where delays in diagnosis often lead to worse outcomes. Drug Resistance Studies With the alarming rise of Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB), the Foundation is researching the genetic mutations and mechanisms driving drug resistance. This research focuses on understanding how TB bacteria adapt and survive existing treatments, enabling the design of new and effective therapeutics. Therapeutic Advancements The Foundation is exploring alternative treatment regimens and novel drugs to address limitations in current TB treatments. The goal is to reduce treatment duration, minimize side effects, and improve patient adherence to ensure higher success rates. Epidemiological and Community-Based Research Admighty Foundation conducts field studies to map TB trends and understand the socio-economic factors influencing TB prevalence and treatment outcomes. This research helps identify high-risk populations and tailor interventions to address their specific needs. Vaccine Development and Efficacy Recognizing the limited efficacy of the Bacille Calmette-Guérin (BCG) vaccine in adults, the Foundation collaborates with research institutions to develop more effective vaccines. These efforts aim to provide long-term immunity and address new and drug-resistant TB strains. Nutrition and Immunity Studies The Foundation explores the link between malnutrition, immunity, and TB susceptibility. Research in this area focuses on how nutritional interventions can support immune system function and improve recovery rates among TB patients, especially in impoverished communities. Technology Integration Leveraging technology, Admighty Foundation is researching ways to incorporate digital health tools, such as mobile apps and AI-based systems, to monitor patient adherence, provide treatment reminders, and analyze epidemiological data for real-time decision-making. Advocacy and Public Health Initiatives In addition to research, Admighty Foundation integrates advocacy efforts into its TB programs by: Running awareness campaigns to educate communities about TB prevention, symptoms, and the importance of early diagnosis. Addressing the stigma associated with TB, which often discourages patients from seeking timely treatment. Promoting adherence to treatment regimens through patient-centric education and support programs. Collaborative Efforts Admighty Foundation adopts a collaborative approach, partnering with: Research institutions and universities for joint studies. Government health departments to align research with national TB elimination strategies. International health organizations, such as the World Health Organization, to contribute to global TB initiatives. Contribution to Global Goals Admighty Foundation’s TB research aligns with: The End TB Strategy by the World Health Organization, which aims to reduce TB deaths and incidence rates by 2035. United Nations Sustainable Development Goal 3 (SDG 3), focused on ensuring healthy lives and promoting well-being for all by combating infectious diseases like TB. Vision for a TB-Free Future Admighty Foundation envisions a future where TB is no longer a global health threat. By combining cutting-edge research, community-centric solutions, and collaborative efforts, the Foundation is making strides toward a world free from TB. Its focus on innovation, accessibility, and sustainability ensures that its work has a long-lasting impact on public health outcomes globally. Through its dedication to research and advocacy, Admighty Foundation continues to inspire hope and contribute meaningfully to the fight against Tuberculosis. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | June 20, 2020 |
| Last updated: | January 28, 2025 |